We are live on
!
Find out more
ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
139 hedge funds and large institutions have $1.11B invested in Alder Biopharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 49 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
29% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 17
24% more capital invested
Capital invested by funds: $893M → $1.11B (+$213M)
3% more funds holding
Funds holding: 135 → 139 (+4)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
22% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 49
87% less call options, than puts
Call options by funds: $1.88M | Put options by funds: $14.6M
Holders
139
Holders Change
+4
Holders Change %
+2.96%
% of All Funds
3.18%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
22
Increased
38
Reduced
49
Closed
17
Calls
$1.88M
Puts
$14.6M
Net Calls
-$12.8M
Net Calls Change
+$2.17M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$22.7M |
| 2 |
SC
Samlyn Capital
New York
|
+$16.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$11.8M |
| 4 |
LPC
Lion Point Capital
New York
|
+$8.84M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.5M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$14.7M |
| 2 |
SAM
Senzar Asset Management
New York
|
-$11.2M |
| 3 |
Axa
Paris,
France
|
-$8.18M |
| 4 |
BlackRock
New York
|
-$6.98M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.59M |
